SCHEMBL19212166

SCHEMBL19212166

CC(C)(C)OC(=O)NC1CN(Cc2ccccc2)CC1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
USP30 Q70CQ3 1/20 0.47
NPFFR1 Q9GZQ6 1/20 0.44
NPFFR2 Q9Y5X5 1/20 0.44
BCHE P06276 3/20 0.44
MAOB P27338 2/20 0.43
DRD2 P14416 4/20 0.42
DRD4 P21917 4/20 0.42
DRD3 P35462 4/20 0.42
RIPK1 Q13546 2/20 0.41
KDM1A O60341 1/20 0.41
KCNA3 P22001 1/20 0.41
S1PR1 P21453 1/20 0.41
S1PR5 Q9H228 1/20 0.41
JAK1 P23458 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA7 P43166 1/20 0.41
CA14 Q9ULX7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1467719 0.90 KMT2A (0.53) KMT2AL3MBTL1NPFFR1NPFFR2BCHE
SCHEMBL1467723 0.90 KMT2A (0.53) KMT2AL3MBTL1NPFFR1NPFFR2BCHE
SCHEMBL17185074 0.90 KMT2A (0.53) KMT2AL3MBTL1NPFFR1NPFFR2BCHE
SCHEMBL1467721 0.90 KMT2A (0.53) KMT2AL3MBTL1NPFFR1NPFFR2BCHE
SCHEMBL3187533 0.88 KMT2A (0.55) KMT2AL3MBTL1NPFFR1NPFFR2BCHE
SCHEMBL7835003 0.88 KMT2A (0.55) KMT2AL3MBTL1NPFFR1NPFFR2BCHE
SCHEMBL19121559 0.88 KMT2A (0.55) KMT2AL3MBTL1NPFFR1NPFFR2BCHE
SCHEMBL7834998 0.88 KMT2A (0.55) KMT2AL3MBTL1NPFFR1NPFFR2BCHE
SCHEMBL3187519 0.88 KMT2A (0.55) KMT2AL3MBTL1NPFFR1NPFFR2BCHE
SCHEMBL1781856 0.88 KMT2A (0.55) KMT2AL3MBTL1NPFFR1NPFFR2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414252-A1 THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS Forma Therapeutics, Inc. (US) 2018-12-19 EP disclosed
WO-2017139778-A1 THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS FORMA THERAPEUTICS, INC. (US) 2017-08-17 WO disclosed